- Home
- ZOM
ZOM
Zomedica Corp.
as 07-26-2024 4:00pm EST
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | ANN ARBOR |
| Market Cap: | 147.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 2.5M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.04 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.12 - $0.23 | Next Earning Date: | 08-08-2024 |
| Revenue: | $25,966,000 | Revenue Growth: | 25.68% |
| Revenue Growth (this year): | 36.75% | Revenue Growth (next year): | 14.92% |
Stock Insider Trading Activity of Zomedica Corp. (ZOM)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Klass Russell Kevin | ZOM | Vice President of Sales | Jun 12 '24 | Buy | $0.16 | 299,993 | $46,528.91 | 2,000,050 | SEC Form 4 |
| Klass Russell Kevin | ZOM | Vice President of Sales | Jun 10 '24 | Buy | $0.15 | 200,007 | $29,941.05 | 1,200,057 | SEC Form 4 |
| Klass Russell Kevin | ZOM | Vice President of Sales | Jun 10 '24 | Buy | $0.15 | 500,000 | $75,100.00 | 1,700,057 | SEC Form 4 |
| Donato Peter | ZOM | Chief Financial Officer | Jun 10 '24 | Buy | $0.15 | 25,000 | $3,797.50 | 25,000 | SEC Form 4 |
| POWERS JOHNNY D | ZOM | Director | May 17 '24 | Buy | $0.18 | 50,000 | $8,950.00 | 2,175,000 | SEC Form 4 |
| POWERS JOHNNY D | ZOM | Director | May 17 '24 | Buy | $0.17 | 50,000 | $8,500.00 | 2,225,000 | SEC Form 4 |
| POWERS JOHNNY D | ZOM | Director | May 16 '24 | Buy | $0.18 | 25,000 | $4,600.00 | 2,125,000 | SEC Form 4 |
| POWERS JOHNNY D | ZOM | Director | May 14 '24 | Buy | $0.14 | 19,406 | $2,697.43 | 2,069,406 | SEC Form 4 |
| POWERS JOHNNY D | ZOM | Director | May 14 '24 | Buy | $0.14 | 30,594 | $4,283.16 | 2,100,000 | SEC Form 4 |
| HEATON LARRY C II | ZOM | CEO | May 13 '24 | Buy | $0.14 | 100,000 | $14,200.00 | 300,000 | SEC Form 4 |
| POWERS JOHNNY D | ZOM | Director | May 13 '24 | Buy | $0.14 | 100,000 | $14,000.00 | 2,050,000 | SEC Form 4 |
| Blair Anthony K | ZOM | COO | May 13 '24 | Buy | $0.14 | 150,000 | $21,000.00 | 150,000 | SEC Form 4 |
| POWERS JOHNNY D | ZOM | Director | Dec 15 '23 | Buy | $0.17 | 100,000 | $16,500.00 | 1,950,000 | SEC Form 4 |
| POWERS JOHNNY D | ZOM | Director | Nov 17 '23 | Buy | $0.17 | 100,000 | $16,600.00 | 1,850,000 | SEC Form 4 |
| HEATON LARRY C II | ZOM | CEO | Nov 17 '23 | Buy | $0.17 | 100,000 | $16,600.00 | 200,000 | SEC Form 4 |
| POWERS JOHNNY D | ZOM | Director | Nov 15 '23 | Buy | $0.17 | 150,000 | $25,950.00 | 1,750,000 | SEC Form 4 |
Latest Zomedica Corp. News
ZOM Breaking Stock News: Dive into ZOM Ticker-Specific Updates for Smart Investing
Argus Research
13 hours ago
Daily – Vickers Top Insider Picks for 07/26/2024
Argus Research
2 days ago
Daily – Vickers Top Insider Picks for 07/25/2024
Argus Research
3 days ago
Daily – Vickers Top Insider Picks for 07/24/2024
Argus Research
4 days ago
Daily – Vickers Top Insider Picks for 07/23/2024
Argus Research
5 days ago
Daily – Vickers Top Insider Picks for 07/22/2024
Argus Research
7 days ago
Daily – Vickers Top Insider Picks for 07/19/2024
Argus Research
7 days ago
Daily – Vickers Top Insider Picks for 07/19/2024
Argus Research
8 days ago
Daily – Vickers Top Insider Picks for 07/18/2024
Compare ZOM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZOM Zomedica Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.